Playlist


TSU and Xinjiang Normal University Enhance Academic Cooperation
18 Apr. 04:49Magtymguly Turkmen State University recently hosted a delegation from Xinjiang Normal University (PRC) to discuss expanding inter-university ties. The meeting was attended by university administration, faculty members, and students. The primary focus of the visit was to establish practical frameworks for bilateral academic engagement and collaboration.
During the dialogue, the parties reviewed the current status of educational partnership between Turkmenistan and China. Significant emphasis was placed on exchanging expertise regarding professional training and the execution of joint research initiatives. Participants highlighted that consistent communication is essential for advancing the overall quality of higher education.
The discussion agenda covered the modernization of curricula and the integration of international best practices into the academic environment. Representatives from both institutions expressed a strong interest in developing academic mobility programs for students and staff. Such initiatives are expected to provide insights into the innovative teaching methodologies utilized in both nations.
Following the discussions, specific vectors for long-term partnership in science and education were identified. According to the official website of TSU, these meetings play a crucial role in strengthening the humanitarian dialogue between Turkmenistan and the PRC. Both sides agreed to maintain their commitment to pursuing collaborative educational goals in the coming years.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.